Nasmed Ozel Saglik Stock Cash Flow From Operations
EGEPO Stock | 26.30 0.82 3.02% |
Nasmed Ozel Saglik fundamentals help investors to digest information that contributes to Nasmed Ozel's financial success or failures. It also enables traders to predict the movement of Nasmed Stock. The fundamental analysis module provides a way to measure Nasmed Ozel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nasmed Ozel stock.
Nasmed |
Nasmed Ozel Saglik Company Cash Flow From Operations Analysis
Nasmed Ozel's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Competition |
In accordance with the recently published financial statements, Nasmed Ozel Saglik has 0.0 in Cash Flow From Operations. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Cash Flow From Operations (which currently averages 0.0) industry. This indicator is about the same for all Turkey stocks average (which is currently at 0.0).
Nasmed Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nasmed Ozel's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nasmed Ozel could also be used in its relative valuation, which is a method of valuing Nasmed Ozel by comparing valuation metrics of similar companies.Nasmed Ozel is currently under evaluation in cash flow from operations category among its peers.
Nasmed Fundamentals
Return On Equity | 0.0238 | |||
Return On Asset | 0.0221 | |||
Profit Margin | 0.03 % | |||
Operating Margin | 0.06 % | |||
Shares Owned By Insiders | 8.00 % | |||
Revenue | 229.67 M | |||
Gross Profit | 40.73 M | |||
EBITDA | 31.65 M | |||
Book Value Per Share | 2.45 X | |||
Earnings Per Share | 0.14 X | |||
Number Of Employees | 851 |
About Nasmed Ozel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nasmed Ozel Saglik's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nasmed Ozel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nasmed Ozel Saglik based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nasmed Stock
Nasmed Ozel financial ratios help investors to determine whether Nasmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nasmed with respect to the benefits of owning Nasmed Ozel security.